Exagen (XGN) Shares Outstanding (2018 - 2026)

Exagen (XGN) has 9 years of Shares Outstanding (Entity) data on file, last reported at $24.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 34.2% year-over-year to $24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.1 million (up 34.2% YoY) and the FY2025 annual result came in at $22.9 million, up 29.88% from the prior year.
• Shares Outstanding (Entity) grew to $24.1 million in Q1 2026, from $22.9 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $24.1 million in Q1 2026 to a low of $16.2 million in Q1 2022.
• A 5-year average of $18.4 million and a median of $17.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) gained 0.82% — and 2026, when it jumped 34.2%.
• Tracing XGN's Shares Outstanding (Entity) over 5 years: stood at $16.5 million in 2022, then climbed by 3.0% to $17.0 million in 2023, then climbed by 3.49% to $17.6 million in 2024, then grew by 29.88% to $22.9 million in 2025, then increased by 5.13% to $24.1 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $24.1 million (Q1 2026), $22.9 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.